Research News
View articles by month and year
-
Adding Taxotere to Standard Chemo Doesn’t Seem to Help Treat Early-Stage Breast Cancer
Taxotere doesn't seem to offer any benefits in treating early-stage breast cancer and also causes more serious side effects.
-
Older Women Do Better on Conventional Chemo Compared to Xeloda
Research shows that women older than 65 do better on standard intravenous chemotherapy after surgery to remove early-stage breast cancer than Xeloda (chemical name: capecitabine), an oral chemotherapy.
-
HER2 and Topo II Status Affects Response to Anthracycline Chemo
A new study suggests that anthracycline-based chemotherapy regimens should be used to treat only HER2-positive breast cancers.
-
Scientists Report on New Breast Cancer Treatments
A number of studies are looking at new ways to treat breast cancer, including testing the effectiveness of new compounds and new uses for current medicines.
-
Zometa Seems to Improve Response to Chemotherapy
Research suggests that Zometa, a medicine used to strengthen bones, may slow breast cancer growth.
-
New Chemo Meds Improve Survival for Women with Advanced-Stage Disease
Newer chemotherapy medicines and regimens, as well as targeted therapy medicines, are helping women with advanced-stage breast cancer live longer.
-
Xeloda and Avastin Combo Better Than Xeloda Alone for Metastatic Disease
The combination of Xeloda (chemical name: capecitabine) and Avastin (chemical name: bevacizumab) has been shown to stop metastatic breast cancer from growing longer than Xeloda alone.
-
Cancers Resistant to Anthracyclines May Respond to Taxotere-Xeloda Combo
A new study suggests that breast cancer that is resistant to an anthracycline may respond to a combination of two other chemotherapies, Taxotere (chemical name: docetaxel) and Xeloda (chemical name: capecitabine).
-
Zometa During and After Chemo Helps Keep Bones Strong
A small study shows that Zometa (chemical name: zoledronic acid) given during and after chemotherapy for early-stage breast cancer maintained bone health in pre-menopausal women.
-
Actonel Boosts Bone Health After Chemo
Actonel (chemical name: risendronate), a bone-strengthening medicine, can improve bone health after chemotherapy for breast cancer. Actonel can also lessen the bone weakening that sometimes happens when hormonal therapy is used after chemotherapy.
